Implementation of infection control best practice in intensive care units throughout Europe: a mixed-method evaluation study by Sax, Hugo et al.
Implementation
Science
Sax et al. Implementation Science 2013, 8:24
http://www.implementationscience.com/content/8/1/24STUDY PROTOCOL Open AccessImplementation of infection control best practice
in intensive care units throughout Europe: a
mixed-method evaluation study
Hugo Sax1,2*, Lauren Clack1,2, Sylvie Touveneau1, Fabricio da Liberdade Jantarada1, Didier Pittet1, Walter Zingg1
and PROHIBIT study groupAbstract
Background: The implementation of evidence-based infection control practices is essential, yet challenging for
healthcare institutions worldwide. Although acknowledged that implementation success varies with contextual
factors, little is known regarding the most critical specific conditions within the complex cultural milieu of varying
economic, political, and healthcare systems. Given the increasing reliance on unified global schemes to improve
patient safety and healthcare effectiveness, research on this topic is needed and timely. The ‘InDepth’ work package
of the European FP7 Prevention of Hospital Infections by Intervention and Training (PROHIBIT) consortium aims to
assess barriers and facilitators to the successful implementation of catheter-related bloodstream infection (CRBSI)
prevention in intensive care units (ICU) across several European countries.
Methods: We use a qualitative case study approach in the ICUs of six purposefully selected acute care hospitals
among the 15 participants in the PROHIBIT CRBSI intervention study. For sensitizing schemes we apply the theory
of diffusion of innovation, published implementation frameworks, sensemaking, and new institutionalism. We
conduct interviews with hospital health providers/agents at different organizational levels and ethnographic
observations, and conduct rich artifact collection, and photography during two rounds of on-site visits, once before
and once one year into the intervention. Data analysis is based on grounded theory. Given the challenge of
different languages and cultures, we enlist the help of local interpreters, allot two days for site visits, and perform
triangulation across multiple data sources.
Qualitative measures of implementation success will consider the longitudinal interaction between the initiative
and the institutional context. Quantitative outcomes on catheter-related bloodstream infections and performance
indicators from another work package of the consortium will produce a final mixed-methods report.
Conclusion: A mixed-methods study of this scale with longitudinal follow-up is unique in the field of infection
control. It highlights the ‘Why’ and ‘How’ of best practice implementation, revealing key factors that determine
success of a uniform intervention in the context of several varying cultural, economic, political, and medical systems
across Europe. These new insights will guide future implementation of more tailored and hence more successful
infection control programs.
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Importance of healthcare-associated infections
Healthcare-associated infections (HAI) represent the most
frequent adverse event affecting hospitalized patients,
resulting in increased morbidity and mortality, longer hos-
pital stay, and disability [1]. In the European Union, the an-
nual number of HAIs can be estimated at approximately
4.5 million, with approximately 37,000 deaths as a direct
consequence, and 16 million extra-days of hospital stay per
year [2]. The risk of acquiring HAI is especially significant
in intensive care units (ICU), where the World Health
Organization (WHO) estimates that approximately 30% of
patients are affected by one or more episodes of HAI with
associated morbidity and mortality [3]. Catheter-related
bloodstream infections (CRBSI) are among the leading
HAI, together with urinary tract infections, surgical site
infections, and ventilator-associated pneumonia [4]. CRBSI
are both prototypical of the causes and preventive
mechanisms of HAI, and are more distinctly defined than
other HAIs [5]. Moreover, CRBSI rates are widely and con-
sistently available among European hospitals [6].
Prevention of vascular catheter-related bloodstream
infection
Evidence indicates that CRBSI rates are amenable to
substantial reduction by the application of stringent
procedures and technological inventions [7]. Hand hy-
giene promotion and implementation of a bundle of
targeted interventions for catheter-related infections are
effective to prevent CRBSI [8-11]. It has been estimated
that at least 56% of CRBSI could be prevented [12,13].
Guidelines typically include elements to assure sterile in-
sertion and handling of central vascular catheters
(CVC). These guidelines recommend less infection
prone insertion sites, effective skin antisepsis, the use of
specific catheter types, scheduled changes of device ma-
terial and dressings, and formal training of involved
healthcare workers with the use of checklists [14]. While
dramatic successes in preventing CRBSI have been
reported for more than a decade [8,9] guidelines are
most likely not uniformly and successfully implemented
in all European hospitals [15-17]. As another approach
to reduce HAI, hand hygiene promotion has been
associated with reduced incidence of bloodstream infec-
tion [18-20], but evidence from a randomized controlled
trial is still lacking [21]. Hand hygiene performance
remains suboptimal in most healthcare settings [22].
Implementation of infection control best practices
It has now been widely accepted that infection control
procedures be evidence-based. Yet, there is a large vari-
ability in how successfully hospitals implement programs
and procedures to protect patients against HAI [23].
Only recently has more attention been devoted tofinding out why wide variations exist in abilities of
hospitals to translate evidence into practice [15-17].
Such variations in implementation success do not only
depend on the quality of intervention programs but may
likely be due to differences in the organizational context,
which Øvretveit defines as ‘all factors that are not part
of a quality improvement intervention itself ’ [24]. Con-
textual factors are often cited as playing a role in the
varied success of best practice interventions; however,
existing literature reporting on implementation strat-
egies often lacks details about specific contextual factors,
and provides limited information about the real barriers
and facilitators to implementation [25,26]. This is of par-
ticular importance given the present backdrop marked
by a wide variety of cultures, healthcare organizations,
and economies across European countries [27].
Thus, we are seeking to fill this gap in the field of in-
fection control by following the call for further research
by Greenhalgh et al. and answering the question: ‘By
what processes are particular innovations in health ser-
vice delivery and organization implemented and
sustained (or not) in particular contexts and settings,
and can these processes be enhanced?’ [28].
Methods
The PROHIBIT consortium study and its work packages
PROHIBIT consortium overall study design
This protocol is nested in a larger, consortium-led,
European Union-funded study under the title ‘Prevention
of Hospital Infections by Intervention and Training’
(PROHIBIT) [29], part of the European Commission 7th
Framework Program (FP7) [30]. The aim of PROHIBIT is:
to understand existing guidelines and practices to prevent
healthcare associated infections in European hospitals; to
identify factors that enable and prevent compliance with
best practices; and to test the effectiveness of interventions
of known efficacy. Through its multiple work packages,
PROHIBIT employs a mixed-methods approach, combin-
ing the strengths of a systematic review, quantitative
surveys, qualitative research, and a randomized controlled
intervention trial. Table 1 lists and briefly describes the six
work packages of PROHIBIT.
PROHIBIT work package 5: a randomized controlled
intervention study
The PROHIBIT work package 4 (WP4), ‘InDepth’ follows
the implementation of the CRBSI prevention initiative
led by the PROHIBIT WP5 group out of Groningen,
The Netherlands. WP5 tests the effect of two different
approaches to CRBSI prevention (WHO hand hygiene
promotion strategy and catheter bundle) in a three-arm,
stepped wedged cluster-randomized controlled trial in a
voluntary-based sample of 15 hospitals across Europe.
The primary outcome for WP5 is the CRBSI rate.
Table 1 PROHIBIT work packages and their objectives
Work
package
(WP)
Title Objective
WP 1 Project Management Ensure that the project’s main scientific objectives are realized on
schedule and on budget.
WP 2 Systematic review of European guidelines for HAI-prevention,
surveillance and public HAI reporting
Detect and analyze current guidelines and recommendations in
European countries for HAI-prevention of HAI. In addition, this work
package will review HAI surveillance activities and schemes and
public HAI reporting efforts in European countries.
WP 3 Survey of policy and practice for HAI-prevention in European
hospitals
Assess the activity of European hospitals in HAI-prevention using a
questionnaire of key determinants in a sample of hospitals in all
European countries.
WP 4
(‘InDepth’)
In-depth qualitative investigation of success factors for adoption
and implementation of infection prevention practices
Identify facilitators and barriers for successful adoption and
implementation of evidence-based infection prevention practices
by European hospitals.
WP 5 Randomized effectiveness trial of two interventions to reduce
catheter-related blood stream infections
Demonstrate the effectiveness of implementation of two
interventions to prevent CRBSI: 1) the WHO hand hygiene
promotion strategy and 2) a CRBSI prevention bundle.
WP 6 Synthesis and dissemination Provide tools for HAI-prevention to be used by stakeholders at
multiple levels of health care systems.
CRBSI, catheter-related bloodstream infection; HAI, healthcare-associated infection(s); WHO, World Health Organization.
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The PROHIBIT WP5 organization and intervention
strategies are described in Table 2. Intervention strat-
egies 1, 2 or both have been sequentially rolled out in
the 15 study hospitals over a period of at least 12 -
months, preceded by a baseline period of at least 6 -
months and an intervention period of 12 to 24 months.
PROHIBIT ‘InDepth’ work package: a qualitative inquiry
The present manuscript focuses on ‘InDepth.’ We pur-
sue our qualitative inquiry in 6 of the 15 PROHIBIT
WP5 study hospitals.
The “InDepth” qualitative inquiry asks two questions:Table 2 PROHIBIT work package 5 (WP5) organization and in
Organization In each hospital, an onsite investigator has the primar
equivalent of a study nurse is paid by PROHIBIT who i
outcomes, and implementing hand hygiene promotio
the hospital is randomized to. Study nurse received tr
Intervention The study intervention includes focus group meetings
and intensive care physicians). Upon the meetings, th
delivered, and the participants will be trained in perfo
hygiene. Furthermore, a practical workshop on how to
net) was organized, and they were provided with info
Intervention
strategy 1
WHO hand hygiene promotion strategy based on ma
Switzerland [31,32]. The five essential elements of the
hand rub at the point of patient care and/or access to
education of health-care professionals; 3) monitoring
the workplace; 5) the creation of a hand hygiene safe
and senior hospital managers.
Intervention
strategy 2
CRBSI prevention bundle according to the Geneva mo
CVC insertion (sterile gloves, cap, gown, large drape);
as the preferred insertion site; 5) early central line rem
CRBSI, catheter-related bloodstream infection; CVC, central vascular catheter; WHO,1. ‘Why are some hospitals/ICUs better at
implementing CRBSI prevention than others?’
2. ‘What are the main barriers and facilitators to
successful implementation of best practice in CRBSI-
prevention?’
Taking advantage of quantitative results on the process
and outcome level produced by WP5, the findings
produced by ‘InDepth’ will ultimately be reported as a
mixed-methods study.
Theoretical framework for the ‘InDepth’ inquiry
Implementation model: diffusion of innovation Our
model of the PROHIBIT WP5 implementation scenario
follows a simplified scheme in a temporal stream based onterventions
y responsibility for the local study-organization. Additionally, 0.5 full-time
s responsible for performing CRBSI surveillance, measuring process
n and catheter care training, depending on which intervention package
aining in hand hygiene and CRBSI surveillance in Geneva, Switzerland.
with healthcare professionals of the participating hospitals (study nurses
e most recent evidence in CRBSI prevention and hand hygiene is
rming practical simulator training of catheter insertion and hand
use a web-based e-learning tool for catheter care (www.carepractice.
rmation about how to implement an intervention program successfully.
terials designed by WHO and the University of Geneva Hospitals,
strategy are: 1) system change, including availability of alcohol-based
a safe, continuous water supply and soap and towels; 2) training and
of hand hygiene practices and performance feedback; 4) reminders in
ty culture with the participation of both individual healthcare workers
del [33-35]: 1) hand hygiene; 2) maximal barrier precaution measures at
3) skin antisepsis with alcohol-based chlorhexidine; 4) subclavian access
oval.
World Health Organization.
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institutions would: 1) learn about PROHIBIT by invitation
as members of the European Antimicrobial Resistance Sur-
veillance System (EARSS); 2) make the decision to partici-
pate in PROHIBIT (adoption decision); 3) prepare the
participation (appointing an onsite investigator, hiring a
study nurse, informing ICU-leaders, building consen-
sus); 4) start to monitor defined study outcomes
(CRBSI-surveillance, hand hygiene observations); 5)
launch their implementation process to align with the
PROHIBIT protocol (re-writing of protocols, training
of healthcare workers, evaluations, etc.); 6) institutionalize
the intervention content. We are aware that, in real-
ity, this process is likely to be much more iterative
and complex.
Sensitizing schemes
Summarizing literature on diffusion of innovation [28]
and implementation science [28,37] served as sensitizing
schemes for this inquiry. Furthermore, we exposed our-
selves to the theories of sensemaking [38] and new insti-
tutionalism [39]. For our purposes, we interpret new
institutionalism as prolongation of sensemaking.
According to this logic, individuals discovering some-
thing new will undergo a period during which they
should make sense of it (name, categorize and relate it
to concepts they are already familiar with) before it
becomes part of the institution, aligning with social
norms and expectations. The ‘Consolidated Framework
for Implementation Research’ (CFIR) served us as a
landscape constituted of numerous validated theories
that facilitate translation of research findings into prac-
tice [37]. This framework also incorporates the extensive
literature review and diffusion of innovation framework
by Greenhalgh et al. [28].
Researchers’ influential backgrounds
Most of our research team members are healthcare
workers and infection control specialists with an exten-
sive past of leading promotional schemes and research.
Thus, at the outset of the study, the team was familiar
with elements of good infection control and patient
safety activities, and the common challenges faced in
achieving quality clinical practice.
Study definitions and procedures
Qualitative research Study design and execution of
‘InDepth’ follows established criteria for qualitative re-
search [40,41]. In the face of non-linear causality and
complex interactions of adoption and implementation
[42], qualitative research methods are particularly suit-
able to put quantitative findings into perspective, in par-
ticular when conceived as mixed-method studies [40,43-
45]. The setting in this study is extremely complex andits elements interconnected given the variation in cul-
ture, healthcare systems, political and economic back-
ground, and infection control policies in Europe. This
has been confirmed by unpublished preliminary results
of PROHIBIT Work Packages 2 and 3. All of these con-
textual factors play an important role in the varied suc-
cess of best practice interventions. In the context of
implementation, such factors have been referred to as
‘conditions for improvement’ [24] and include elements
that are both internal (e.g., interpersonal relationships,
safety culture, structural organizational characteristics)
and external (e.g., national regulations and financial
incentives) to the implementing organization.
Case study method
We chose a case-study methodology with longitudinal
follow-up to guide the qualitative investigation [46]. This
approach is especially valuable for ‘InDepth’, as it allows
for the investigation of the implementation phenomenon
where the boundaries are not clearly defined between
the context and the implementation itself. This may be
intrinsically important to implementation success [47].
Case definition
The hospital is the unit of randomization considered for
WP5, and consequently, we define each hospital as a pri-
mary case. Within each hospital case, we anticipate that
individual nested case studies will emerge that detail the
ICU-level or individual-level experiences, for example
[46]. These nested, micro-case studies will serve to en-
rich the understanding of the overall primary cases.
Study hospital sampling strategy and procedure
Six hospitals were purposefully selected among the 15
WP5 intervention study hospitals based on the scheme
of ‘extremes’ and ‘intensity’ [46,48]. Evaluation was
performed by online questionnaire and telephone
interviews with the onsite investigator to identify
information-rich cases. While the questionnaire asks
about concrete information like local healthcare, struc-
ture and organization of the institution and infection
control, the interview confirmed questionnaire
responses and provided more subtle information
about the context of the institution. We identified six
hospitals that would demonstrate the nature of the
implementation process: three hospitals with a strong
potential to succeed more easily, and three hospitals
that would have to face more challenges to imple-
ment the PROHIBIT CRBSI and hand hygiene
intervention.
Defining implementation success
Implementation success is defined and assessed on sev-
eral levels in this study. Reduction of CRBSI will be the
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herence to good practice will represent process quality.
These measures will be produced under the WP5 proto-
col. To these numeric outcomes, we added a qualitative
definition of successful implementation: the satisfaction
of our interviewees with the intervention program, and
the implementation process and outcome; the extent of
‘intervention fidelity’ (adherence to core content); and
successful resolution of intervention-context fit issues
(adaptation, local re-engineering, and innovation). Care-
ful reflexivity and triangulation among the different
sources of qualitative information will reflect the validity
of this qualitative outcome measure [46].On- and off-site data collection procedures
Onsite visits take place one month before and one year
after the intervention launch (Figure 1). They include 10
to 15 interviews (Table 3) with key professionals from
various levels and departments who were identified in ad-
vance or ad hoc (Table 4), and 2 to 3 ethnographic
observations of 2 to 3 hours each in the ICUs focusing on
ergonomic outlines, work attitude, hand hygiene behavior,
catheter handling, and collection of written protocols.
Three months into the implementation, additional tele-
phone interviews with the onsite investigator wereFigure 1 Temporal scheme of study procedures.conducted to follow up on the implementation process. In
addition, these follow-up telephone interviews and second
site visits allow for member checking, i.e., to verify our
conclusions with study participants [46].
Staying for two days rather than just one allows us to
take advantage of the exposure re-exposure effect [46]
and to account for any Hawthorn effect. More details on
the ‘InDepth’ data collection procedures can be found in
Table 5.Ethics approval
‘InDepth’ procedures were part of the document
approved by the Institutional Review Boards of the 15
institutions participating in the PROHIBIT WP5 trial.Analysis
We employ a ‘grounded approach’ to data analysis,
which provides the opportunity to empirically build the-
ory and identify new determinants and patterns rather
than fit observations to existing frameworks and models
[40,44,46]. This research process is iterative and emer-
gent such that interim findings may influence the on-
going data collection. The case-level analysis is informed
by Strauss and Corbin’s defined processes of grounded
Table 3 A typical ‘InDepth’ interview guide
Interviewee background Personal career?
Role in the organization?
Team environment and tasks?
Biggest challenge What is your biggest challenge at work at this moment?
Healthcare associated infections
(HAI)
Personal view of HAI?
Perception of HAI by others in the institution?
Prevention initiatives What were your past experiences with catheter-related bloodstream infections (CRBSI) or other HAI
prevention, if any?
(If no CRBSI experience, any other suitable initiative to discuss implementation was addressed)
Probing for implementation dimensions*
Adoption process How did the institution decide to participate?
Safety culture Is leadership promoting patient safety?
Do collaborators dare to speak up in case of unsafe behavior?
How are critical incidents handled?
Organizational culture Do you like working in this institution? What is great?
Who is important?
Staffing and other resources?
* Probing is based on dimensions and constructs from implementation frameworks [28,37].
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detailed in Table 6.
Reporting
Through this process of multilevel, qualitative and quan-
titative research, we seek to reveal the barriers and
facilitators to implementation success, and to further
identify which factors are recurrent across institutionsTable 4 List of typical ‘InDepth’ criterion-selected
interviewees
Top management level Chief executive officer (CEO)
Director of nursing
Medical director
Infection control program Head of infection control program
Infection control
practitioner(s)/nurse(s)
Infection control physician(s)
Epidemiologist(s)
PROHIBIT onsite investigator
PROHIBIT onsite study nurse
Intensive care unit
(ICU) leaders
ICU head physician
ICU head nurse
ICU frontline healthcare
workers
ICU nurse(s), specialized or
in training
ICU infection control link nurse
Physician(s), specialized or in
training[46]. As formative research, the information gathered
from this inquiry will provide tools that can be used by
stakeholders at multiple levels of healthcare systems,
such as the EU, national policy makers, managers, and
medical professionals, to guide future HAI-prevention
initiatives.
Anticipated outcome of the study
We anticipate finding a set of universal and local
barriers and facilitators for the implementation of infec-
tion control practices from the analysis of all cases. We
predict them to be possible at any level of the institu-
tion, from single individuals, physical environment and
tools, to formal and informal networks; processes inside
the institution or directly linked to the intervention and
the institutions’ and countries’ political, financial and
cultural context. We also hypothesize that combinations
of barriers and facilitators (rather than single most im-
portant determinants) will predict implementation suc-
cess or failure.
Lessons learned so far
Study hospitals started according to the WP5 protocol
with CRBSI surveillance and process measures in Janu-
ary 2011, and the first three study centers were
randomized to launch their intervention in July 2011,
followed by further three centers every quarter, the last
three launching in July 2012 (Figure 1). Information and
workshop days for study nurses were successfully
conducted in Groningen, The Netherlands, and in Gen-
eva, Switzerland. We completed our first series of
Table 5 “InDepth” data collection process
Identifying interviewees Sampling of candidates for interviews follows a ‘criterion strategy’ [46] in order to reach individuals at multiple
levels of the institutional hierarchy and in key departments such as hospital administration, infection control
program, and the intensive care unit (ICU). Additional interviewees are being selected following a ‘snowball
sampling strategy’ based on recommendations of key informants by interview partners. Typical interviewees
include individuals at top-management, ICU, and infection control level. See Table 3 for typical interviewee
profiles. We planned for 10 to 15 interviews per site visit.
Semi-structured interviews and
interview guide
Interviews are approximately one hour long and follow a semi-structured format, according to a ‘general
interview guide approach’ [46]. Two researchers participate in each interview, with one person leading the
conversation and the other backing up for recording, note-taking and occasional jump-in questions.
Interview guides are prepared before each phase of the inquiry, listing questions and issues to be explored
(Table 3). This approach ensures that the same lines of inquiry are explored, while still leaving freedom for
each interviewee to elaborate on topics of particular interest. Interview sections and questions for the first
series of site visits (before the intervention launch) were selected to understand background, position and
network of the interviewee; the interviewee’s perception of healthcare-associated infection as well as those of
other members of the organization; the experience of the institution with past implementation experience to
estimate ‘implementation fitness’ and, more concretely, pre-existing achievements in catheter-related
bloodstream infection prevention; rounding up with a broader view of safety and organizational culture.
Interview guides for the second series of site visits (one year after the launch of the initiative) will be
designed according to the cross-case analysis of the first series and in line with potential suggestions from
the literature at that point in time.
Ethnographic observations Ethnographic observations are useful as a tool for methodological triangulation. These direct, personal
contacts, help us to better understand the context within which people interact, to obtain frank accounts
from spontaneous, brief interviews, and to enrich data with a non-subjective view in agent behavior and
sensemaking [49]. Two researchers perform observations at a time, taking notes when possible about the
setting, activities taking place, who participates, and meaning of what was observed. Immediately after the
observation session of 2 to 3 hours, observers individually produce narratives of the observation that serve as
the primary material for the analysis alongside the interview transcripts. We perform 2 to 3 observation
sessions per site visit.
Photographic documentation Photography allows for documentation of rich, vivid accounts of the reality [46]. We take pictures of locations
and important items, such as insertion sets and hand hygiene dispensers. Shots of the town and countryside
further help to recall the context during the analysis. Additionally, we produce drawings of the unit layouts.
Artifacts collection During site visits, we collect artifacts such as guidelines, written protocols, data collection and audit forms.
Often, these have to be translated for the analysis.
Table 6 ‘InDepth’ case-level analysis scheme
Onsite debriefings and cross-
briefings
Debriefings are conducted following each stage of data collection, during which the involved researchers note
main observations and establish a tentative list of predicted barriers, facilitators, and emerging themes. This
information is then cross-briefed with the remaining researchers while still on-site.
Microanalysis, theme
identification
Following each visit, transcripts are read line-by-line by at least two researchers to identify recurring themes and to
suggest relationships among them. These emerging themes are then discussed among all investigators to establish
a list of main themes.
Open and axial coding,
theme memos
Once the main themes for the site have been established, a process of open and axial coding [46] begins, during
which all written data will be revisited and text will be coded in order to identify concepts and dimensions
covered in the data. This coding is axial in that it identifies manifestations of each theme and its sub-themes at
different levels of the organization, always occurring around the axis of the main theme. This analytical process
results in the creation of theme memos, where each statement is supported by corresponding quotes or references
to the observation narratives or artifacts and pictures.
Case reports Once all theme memos are completed, they are discussed among all investigators to determine which themes are
the most relevant to our central research questions and may have the most important implications on success or
failure of the WP5 intervention. Relational ‘hypotheses’ are formulated about how concepts may relate in order to
better understand phenomena taking place in the institution. All of this information is then compiled into a case
report.
Intermediate and final
reports
The above case-level analysis is completed for each of the six hospitals prior to and following the intervention. By
combining these approaches and by using a sensitizing scheme (being aware of existing evidence of barriers and
facilitators for diffusion of innovation and implementation in organizations) for the preparation and execution of
the inquiry and using a grounded approach (generating theory directly from the material) for the analysis, a
multidimensional picture of structural, organizational and interpersonal contexts will emerge as a basis to define
local and universal barriers and facilitators for infection control interventions.
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this time, case study-level analysis has not been
concluded, and cross-case synthesis has yet to start.
Centers are located in the following regions: Mediter-
ranean, Baltic, British Isles, Alpine arc, and Visegard.
We believe that the sample represents a balanced mix of
different study intervention arms, geographical locations,
and implementation success variation.
Three of the six included centers reside in regions out-
side of our group’s language fluency. We were, however,
always able to organize the 10 to 15 interviews either in
English or in the local language with the help of a local
translator who was not part of the hospital or another
authoritarian agency. We were welcomed in all hospitals
and had no problems finding additional interviewees,
mostly from frontline staff recruited during observations.
The two days of presence in the field (including lunch-
time and evenings in town) offered time for informal ex-
change with hospital contact people and/or the
translator, which helped to enhance understanding of
the wider context of these centers. In more than one in-
stance, our stay was reported to have contributed to the
dynamics of the PROHIBIT WP5 implementation
process. In one instance, it was even seen as a break-
through for the recognition of infection control by the
institution’s leaders. This was unintended but not en-
tirely avoidable, given our group’s background and affili-
ation with PROHIBIT. We tried to limit this by avoiding
feedback or advice, even when solicited by centers.
Moreover, we remained blinded to the quantitative out-
come and performance results of PROHIBIT WP5 for
each site throughout the inquiry.
Discussion
This longitudinal case study is designed to provide con-
textual information to complement the results of the
PROHIBIT intervention study by adding a qualitative,
in-depth inquiry following the implementation of a
CRBSI-prevention and hand hygiene promotion strat-
egies in European ICUs. The results are expected to ex-
plain and to illustrate the epidemiological findings of the
quantitative randomized controlled intervention trial.
Moreover, they are intended to make the findings applic-
able in the sense of formative research.
The sensitizing exposure to theoretical frameworks of
best practice implementation and the investigators’ pro-
fessional experience in the field of infection control will
ultimately help to relate our findings to the existing lit-
erature in both fields. Following existing schemes may
be a barrier to discovering novel findings. We chose a
grounded theory approach for data retrieval and analysis
to counteract such limitations.
Overall, qualitative research methods are particularly ef-
fective to detect concepts and relationships in the contextof high variability and interconnectedness of variables [46].
These contexts are highly applicable to understanding im-
plementation processes. Thus, implementation research is
urgently needed given the demand for unified global
schemes to improve patient safety and healthcare effective-
ness. Production of guidelines, even if based on published
evidence, do not necessarily change healthcare worker prac-
tice [52]. This may be due to the lack of knowledge about
barriers and facilitators inherent in local contexts and
multidimensional patterns. Scientific knowledge on how to
best address structural and organizational issues is scarce;
even large-scale, well-funded patient safety initiatives may
not guarantee success. A multisite quality of care improve-
ment intervention in the United Kingdom based on the In-
stitute of Healthcare Improvement (IHI) template
channeling top management support, ‘walk-arounds’ with
administrators, and the engagement of external change
agents still failed to improve and sustain patient safety to a
large extent [53,54]. The qualitative component of the cited
study revealed enthusiastic top management buy-in at its
commencement. However, enthusiasm failed to reach the
healthcare workers at the bedside. Thus, we will pay special
attention to the vertical alignment and frontline receptive-
ness of the PROHIBIT WP5 intervention.
Protocols and scientific reports on qualitative studies of
implementation of infection control best practice by
others
Although understudied, there is some published qualita-
tive research in the field of organizational factors of infec-
tion control best practice implementation. Uchida et al.
used 23 semi-structured interviews in six acute care
hospitals to gain insight in current practice in infection
control under mandatory surveillance and reporting [55].
They found themes on mandatory reporting, technology
on HAI surveillance, role expansion, and impact of
organizational climate. An interdisciplinary group at the
Veteran Affaires Hospitals and Michigan University in
Ann Arbor has conducted several studies on the imple-
mentation of infection control best practice focusing on
catheter-associated urinary tract infections [23,26,56,57].
They described the importance of champions in the im-
plementation process and their dependency on working
relationships within their organization [57]. It was
considered ineffective to assign the role of champions, as
these individuals are usually not intrinsically motivated.
Further, a published study protocol by Kyratsis and
colleagues describes their qualitative research approach
using in-depth comparative case study design to understand
how healthcare managers draw upon sources of evidence,
and how this translates into decisions about adoption and
implementation of innovations in healthcare [58]. Via
methods including in-depth semi-structured interviews,
observations, and survey questionnaires in nine acute-care
Sax et al. Implementation Science 2013, 8:24 Page 9 of 11
http://www.implementationscience.com/content/8/1/24organizations, they aim to gain a broad understanding of
organizational contextual dynamics, which could inform
policy and decision makers responding to the present need
for organizations to be innovation-ready.
Why is this study unique?
Several features make this study a unique opportunity to
learn more about the conditions under which implemen-
tation of best practices in infection control is likely to be
successful. First, the diverse context of varying cultural,
political and healthcare systems of the study cases will
add robustness to the findings. Second, this background
will be further understood as a result of simultaneous
PROHIBIT work packages on national regulations and
guidelines (WP2), and infection control practices (WP3;
for both, see Table 1). Third, quantitative data for each
hospital on CRBSI outcome, hand hygiene, and max-
imum barrier precautions adherence will allow for a
state-of-the-art mixed-methods analysis [59].
A unique feature of our study methodology is that we
follow the cases longitudinally with site visits before im-
plementation and one year into the implementation of
the PROHIBIT WP5 procedures. Just as a baseline
measurement is essential in experimental study design,
the site visits prior to implementation will be crucial in
establishing a baseline estimate of the organization’s
safety culture and implementation fitness and producing
an inventory of CRBSI prevention measures already in
place in the ‘InDepth’ study hospitals in order to identify
what we call the ‘delta.’ This points to what CRBSI pre-
vention elements the hospitals must actually implement
or modify to achieve full PROHIBIT WP5 best practice
implementation. Moreover, the second site visit allows
for the detection of changes in the organization outside
the PROHIBIT prevention initiative, since this imple-
mentation experience may trigger further changes to-
wards best practice in other areas of the organization,
the organizational structure, or even the safety culture in
the sense of a halo effect.
Limitations
Selection bias
There is some potential bias in the selection of the par-
ticipating hospitals in PROHIBIT WP5. Hospitals first
had to be part of the European Antimicrobial Resistance
Surveillance System (EARSS) to be invited to participate
in PROHIBIT; they had to be of large size to provide a
sufficient number of central catheters; they had to have
English-speaking professionals to serve as onsite
investigators; and they had to have an ICU. Furthermore,
the hospitals had to agree to send physicians and nurses
abroad for training. These are all factors that could bias
our study towards hospitals more receptive to change.
However, we believe that the barriers and facilitators toimplementation will fundamentally apply to more
challenged institutions, even so to a larger extent.Potential bias in researchers
Two study group members were occasionally involved in
the training of ICU physicians and nurses in the centralized
workshops of PROHIBIT WP5. Here, they gained detailed
information regarding participating hospitals and interacted
with HCWs whom they would again see upon one of the
site visits. Obtaining information before the site visit may
contribute bias, but is also a source of useful information.
Heightened attention to reflexivity serves as a safeguard
against this type of bias [60].Conclusions and outlook
With its longitudinal and mixed-method research design
among a variety of healthcare contexts across a multicul-
tural Europe, this study will provide actionable informa-
tion about barriers and facilitators to the implementation
of best practices in infection control. The multicultural
background and numerous logistic and communication
issues do pose some challenges for this research. After
having completed the first round of site visits, however,
we have gained firm confidence in its feasibility and po-
tential for success. We anticipate that, some years later,
these same cases could become the subject of further in-
vestigation into the question of sustainability.Consent
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